Charmacy Pharmaceutical Co., Ltd. (2289.HK)

HKD 9.0

(0.0%)

Revenue Summary of Charmacy Pharmaceutical Co., Ltd.

Charmacy Pharmaceutical Co., Ltd.'s latest annual revenue in 2023 was 4.4 Billion CNY , up 5.47% from previous year.
Charmacy Pharmaceutical Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 2.34 Billion CNY , up 9.96% from previous quarter.
Charmacy Pharmaceutical Co., Ltd. reported a annual revenue of 4.17 Billion CNY in annual revenue 2022, up 10.06% from previous year.
Charmacy Pharmaceutical Co., Ltd. reported a annual revenue of 3.79 Billion CNY in annual revenue 2021, down -4.96% from previous year.
Charmacy Pharmaceutical Co., Ltd. reported a quarterly revenue of 2.26 Billion CNY for 2023 Q2, down -0.84% from previous quarter.
Charmacy Pharmaceutical Co., Ltd. reported a quarterly revenue of 4.4 Billion CNY for 2023 FY, up 5.47% from previous quarter.

Annual Revenue Chart of Charmacy Pharmaceutical Co., Ltd. (2023 - 2013)

Historical Annual Revenue of Charmacy Pharmaceutical Co., Ltd. (2023 - 2013)

Year	Revenue	Revenue Growth
2023	4.4 Billion CNY	5.47%
2022	4.17 Billion CNY	10.06%
2021	3.79 Billion CNY	-4.96%
2020	3.99 Billion CNY	14.28%
2019	3.49 Billion CNY	-11.24%
2018	3.93 Billion CNY	-3.92%
2017	4.09 Billion CNY	11.61%
2016	3.66 Billion CNY	8.03%
2015	3.39 Billion CNY	12.71%
2014	3.01 Billion CNY	25.52%
2013	2.4 Billion CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q2	2.34 Billion CNY	9.96%
2023 Q2	2.26 Billion CNY	-0.84%
2023 FY	4.4 Billion CNY	5.47%
2023 Q4	2.13 Billion CNY	-5.93%
2022 FY	4.17 Billion CNY	10.06%
2022 Q4	2.28 Billion CNY	21.26%
2022 Q2	1.88 Billion CNY	4.8%
2021 FY	3.79 Billion CNY	-4.96%
2021 Q2	1.99 Billion CNY	-6.47%
2021 Q4	1.8 Billion CNY	-9.65%
2020 Q4	2.13 Billion CNY	14.52%
2020 Q2	1.86 Billion CNY	4.26%
2020 FY	3.99 Billion CNY	14.28%
2019 Q4	1.78 Billion CNY	4.48%
2019 Q2	1.7 Billion CNY	-10.72%
2019 FY	3.49 Billion CNY	-11.24%
2018 Q2	2.02 Billion CNY	-7.75%
2018 Q4	1.91 Billion CNY	-5.38%
2018 FY	3.93 Billion CNY	-3.92%
2017 Q4	2.19 Billion CNY	15.12%
2017 FY	4.09 Billion CNY	11.61%
2017 Q2	1.9 Billion CNY	0.64%
2016 Q4	1.89 Billion CNY	6.41%
2016 Q2	1.77 Billion CNY	0.92%
2016 FY	3.66 Billion CNY	8.03%
2015 Q2	1.63 Billion CNY	4.53%
2015 FY	3.39 Billion CNY	12.71%
2015 Q4	1.76 Billion CNY	7.73%
2014 FY	3.01 Billion CNY	25.52%
2014 Q2	1.44 Billion CNY	92.37%
2014 Q4	1.56 Billion CNY	7.93%
2013 FY	2.4 Billion CNY	0.0%
2013 Q4	753.51 Million CNY	0.0%

Peer Revenue Comparison of Charmacy Pharmaceutical Co., Ltd.

Name	Revenue	Revenue Difference
Wanjia Group Holdings Limited	181.09 Million HKD	-2331.711%
China Health Group Limited	59.93 Million HKD	-7247.962%
Tai United Holdings Limited	197.99 Million HKD	-2124.17%